Compugen Ltd. DPO Ratio 2011-2026 | CGEN

Annual DPO Ratio Compugen Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
82.7	123	480	1.2 K	1.62 K	7.61 K	-	1.13 K	-	2.09 K	447	163	101	808	-

All numbers in USD currency

Maximum	Minimum	Average
7.61 K	82.7	1.32 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Heron Therapeutics HRTX	91.4	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	31.7	$ 19.23	-1.38 %	$ 899 M	USA
Aytu BioScience AYTU	186	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Incyte Corporation INCY	200	$ 90.45	-0.36 %	$ 17.7 B	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Kamada Ltd. KMDA	106	$ 8.2	-0.61 %	$ 260 M	Israel
Karyopharm Therapeutics KPTI	149	$ 6.66	-12.71 %	$ 812 K	USA
Clovis Oncology CLVS	236	-	-7.23 %	$ 13 M	USA
Longeveron LGVN	241	$ 0.95	-2.71 %	$ 16.7 B	USA
Arbutus Biopharma Corporation ABUS	23	$ 4.42	4.25 %	$ 734 M	Canada